A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Actym Therapeutics, Inc.
NuCana plc
University of Virginia
Elevation Oncology
Aminex Therapeutics, Inc.
Washington University School of Medicine
ADC Therapeutics S.A.
pharmaand GmbH
Fate Therapeutics
Genmab
Incyte Corporation
AIDS Malignancy Consortium
National Institutes of Health Clinical Center (CC)
Western Regional Medical Center
Cornerstone Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)